|
|
Features Include |
| EPA/DHA Omega-3: |
|
EPA/DHA promote cardiovascular health by supporting healthy triglyceride and lipid metabolism, maintaining
healthy blood flow, and supporting healthy platelet function. Fish oil is also important for optimal joint function.
It maintains healthy prostaglandin and leukotriene production, which is important for maintaining connective
tissue health and comfort. Furthermore, omega-3 fatty acids are important components of neuronal cell
membranes and are essential to cognitive function.
|
|
Benefits Include |
| Cardiovascular Health: |
|
Studies suggest that Omega-3 fatty acids promote healthy lipid and triglyceride metabolism, blood flow, vascular
dilation and tone, platelet function, endothelial function, and erythrocyte membrane composition. Research also
suggests the potential for fish oil to contribute to healthy homocysteine metabolism.*
|
|
| Joint Function: |
|
Omega-3 fatty acids act in part by maintaining healthy prostaglandin, cytokine and leukotriene production,
supporting connective tissue and cartilage integrity. The results of numerous small double blind trials indicate
that the omega-3 fatty acids in fish oil promote joint motility and joint comfort.*
|
|
| Emotional Health: |
|
Omega-3 fatty acids are important components of neuronal cell membranes and are essential to cognitive
function. By supporting vascular health, fish oils promote oxygen and nutrient delivery to the brain. Studies
suggest that healthy red blood cell membrane omega-3 fatty acid concentration is associated with emotional
well-being. Both epidemiological and double blind placebo-controlled trials indicate that Omega-3 fatty acids
supports positive mood.*
|
|
| Cognitive/Visual Development: |
|
Omega-3 fatty acids promote healthy mental function and maturation of the central nervous system, including
support for cell health and neurotransmission. Essential fatty acids are also vital constituents of the retina,
helping to support healthy visual function. EPA and DHA consumption by breast fed infants and children born
to mothers who supplement with fish oils has demonstrated support for visual acuity and cognitive development.
A longitudinal study suggests that infants born to mothers with higher DHA status demonstrated healthy cognitive
capacity at 12 and 18 months. A randomized double blind study suggested that 4 year olds born to mothers
who had taken fish oil had healthy cognitive function. Another study suggested that fish oil supplementation
may enhance healthy night vision in children. Several studies have also revealed a relationship between dietary
omega-3 fatty acids, healthy brain function and sleep patterns.*
|
|
| Gastrointestinal Health: |
|
Omega-3 fatty acid supplementation has been associated with a soothing effect for the gastrointestinal (GI)
tract. In a double blind, placebo-controlled crossover trial, subjects experienced positive support for GI comfort.
A separate 6 month trial revealed that fish oil supplementation maintained healthy leukotriene production
and immune cell activity in the colon.*
|
|
| Skin Health: |
|
Omega-3 fatty acids promote vascular health, supporting oxygen and nutrient delivery to the skin. Studies have shown that omega-3
fatty acids protect keratinocytes and fibroblasts from free radicals and immune mediators generated by sun exposure, helping
to soothe the skin. Additionally, they help promote elasticity and hydration for smoother looking skin.*
The FxOmega oils are purified in a gentle, multi-step molecular distillation process that removes heavy metals, PCBs and dioxins.
Each lot of every product is tested by independent third party labs for:
- heavy metals (parts per billion)
- PCBs, dioxins, furans (parts per trillion)
- oxidative byproducts
- microbial contamination
FxOmega meets or exceeds stringent guidelines, which include strict upper limits for PCBs, dioxins and heavy metals. In addition,
each lot must meet California's Proposition 65 for PCBs, dioxins and heavy metals. FxOmega tests well below the 0.09 mg/kg
maximum level set for PCBs.
|
Recommendations
Helion Nutraceuticals recommends (for adults): 1 to 9 softgels daily, in divided doses.
Maintenance: 1 softgel, 2 times a day.
Therapeutic: 1 to 3 softgels, 3 times a day./p>
One softgel contains: |
 |
| |
| Fish Oil Concentrate (anchovy, sardine) | |
| Providing: | |
| EPA (Eicosapentaeonoic Acid) | 544 mg |
| DHA (Docosahexaenoic Acid) | 408 mg |
| Vitamin E (as d-alpha Tocopherol) | 2.75 IU |
| Total Omega-3 Fatty Acids | 952 mg |
| Other Ingredients: Gelatin, Glycerin | |
|
References
1AKris-Etherton P, Harris W, Appel L. Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. Circulation. 2002;106:2747.
2Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol. 2000 Oct;27(10):2343-6.
3Kremer JM, Lawrence DA, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis
Rheum. 1995 Aug;38(8):1107-14.
4Sundrarjun T, Komindr S, Archararit N, et al. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active
rheumatoid arthritis. J Int Med Res. 2004 Sep-Oct;32(5):443-54.
5Khan F, Elherik K, Bolton-Smith C, Barr R, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc Res.
2003 Oct 1;59(4):955-62.
6Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003 Feb 8;
361(9356):477-85.
7Nestel P, Shige H, Pomeroy S, et al. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr. 2002 Aug;
76(2):326-30.
8Chan DC, Watts GF, Mori TA, et al. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants
in men with visceral obesity. Am J Clin Nutr. 2003 Feb;77(2):300-7.
9Von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern
Med. 1999 Apr ;130(7):554-62.
10Miyajima T, Tsujino T, Saito K, Yokoyama M. Effects of eicosapentaenoic acid on blood pressure, cell membrane fatty acids, and intracellular sodium concentration in essential
hypertension. Hypertens Res. 2001 Sep;24(5):537-42.
11Tagawa T, Hirooka Y, Shimokawa H, et al. Long-term treatment with eicosapentaenoic acid improves exercise-induced vasodilation in patients with coronary artery disease.
Hypertens Res. 2002;25(6):823-9.
12Hamazaki T, Sawazaki S, Itomura M, et al. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest. 1996 Feb 15; 97(4):1129-33.
Download Product Sheet
Download specification sheet [PDF]
|